U.S. Army Captain Michael Kelvington, commander of the Battle company, 1-508 Parachute Infantry battalion, 4th Brigade Combat Team, 82nd Airborne Division, bows next to remains of Gulam Dostager, a member of Afghan Local Police who was killed in the blast of an Improvised Explosive Device (IED) during the joint Tor Janda (Black Flag in Pashtu) operation, in Zahri district of Kandahar province, southern Afghanistan May 25, 2012.  REUTERS/Shamil Zhumatov  (AFGHANISTAN - Tags: MILITARY CIVIL UNREST CONFLICT TPX IMAGES OF THE DAY)

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz (UNITED STATES - Tags: MILITARY ANNIVERSARY TPX IMAGES OF THE DAY)

Fleet Week

The U.S. Navy takes Manhattan for a week.  Slideshow 

Photo

The SpaceX mission

A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station.  Slideshow 

Under 10s may need two swine flu shots: Sanofi

Related Topics

LONDON | Wed Oct 14, 2009 1:42pm EDT

LONDON (Reuters) - Children under 10 years may need two shots of swine flu vaccine to get optimal protection, French drugmaker and the world's biggest flu vaccine producer Sanofi-Aventis said on Wednesday.

A two-dose regimen for H1N1 swine flu would be in line with recommendations for seasonal influenza immunization in children of this age.

Sanofi said results of a U.S. clinical trial looking at H1N1 vaccination in children aged 6 months through 9 years suggested a single dose may protect many children but "two doses of vaccine will be required for optimal protection."

Previous results from studies of swine flu vaccines made by Sanofi and other companies have found one dose offers good protection in adults.

In the case of children, however, only 50 percent of those aged 6 to 35 months had adequate protection after a single shot, while 76 percent of children aged 3 to 9 years were protected. That compares with 98 percent of adults who had a good immune response after just one dose.

Sanofi is the only company licensed in the United States to produce a flu vaccine for children as young as 6 months of age.

A total of 474 children were studied in the clinical trial.

(Reporting by Ben Hirschler; Editing by Hans Peters)

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.